BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Jun 15, 2026; 18(6): 117308
Published online Jun 15, 2026. doi: 10.4251/wjgo.v18.i6.117308
Figure 3
Figure 3 Overall survival by KRAS, PIK3CA, FBXW7 and TP53 status. A: Overall survival (OS) by KRAS status. Log-rank P = 0.012. Hazard ratio (HR) (mutant vs wild-type) from Cox model: 3.57 (95%CI: 1.85-6.89); B: OS by PIK3CA status. Log-rank P = 0.027. HR (mutant vs wild-type) from Cox model: 0.26 (95%CI: 0.09-0.74); C: OS by FBXW7 status. Log-rank P = 0.213. HR (mutant vs wild-type) from Cox model: 1.86 (95%CI: 0.85-4.05); D: OS by TP53 status. Log-rank P = 0.340. HR (mutant vs wild-type) from Cox model: 1.68 (95%CI: 0.87-3.25).


Write to the Help Desk